Skip to Content
Stock Analyst Update

Anthem Remains Undervalued After Solid First Quarter

We are maintaining our fair value estimate for this narrow-moat firm.


Narrow-moat Anthem (ANTM) reported solid first-quarter operating results and, perhaps more importantly given the backdrop of the ongoing COVID-19 crisis, maintained its earnings per share guidance for 2020. We are maintaining our fair value estimate ($348 per share) and believe that Anthem's shares remain undervalued. 

In the first quarter, Anthem reported adjusted earnings per share ($6.48) that mildly beat Capital IQ consensus ($6.44) and allowed the firm to maintain its bottom-line guidance for 2020. Specifically, Anthem still expects to generate at least $22.30 per share in adjusted earnings, which remains in line with our expectations. The company also generated substantial free cash flow of $2.3 billion in the quarter, up from $1.4 billion in the prior-year period. In general, we no longer remain concerned about medical costs spiking out of control in 2020 because of the COVID-19 crisis. Rather, Americans appear to be avoiding healthcare services due to social distancing initiatives, and Anthem estimates that 30% to 40% of its annual medical expenses are related to deferrable elective procedures. 

We believe the major COVID-19 risk relates to the economic downturn due to shelter-in-place orders that are contributing to massive layoffs. If those layoffs are sustained, employer-based membership rolls, which represents roughly 70% of Anthem's membership rolls, will likely decline. However, all else being equal and including the effects of recently generated cash flows on our model, we think Anthem and the other insurers have substantial room for membership to fall in 2020 before we would change our fair values, assuming a mild recovery starting in 2021. Also, we would note that increased insurance rolls for individual and Medicaid business lines (about 20% of Anthem's current membership rolls) could rise and somewhat offset the commercially insured losses for insurers like Anthem, as well, during a slow economic period.

Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.

Julie Utterback does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.